Log in to save to my catalogue

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute h...

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute h...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f4c525969e244f379e199d34138ac9d7

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis

About this item

Full title

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2022-02, Vol.21 (1), p.20-8, Article 20

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

There is uncertainty and limited data regarding initiation of sodium-glucose cotransporter 2 (SGLT2) inhibitors among patients hospitalized with acute heart failure (AHF). This systematic review and meta-analysis aim to establish the efficacy and safety of SGLT2 inhibitors initiated in patients hospitalized for AHF.
PubMed/Medline, Embase, and C...

Alternative Titles

Full title

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f4c525969e244f379e199d34138ac9d7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f4c525969e244f379e199d34138ac9d7

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-022-01455-2

How to access this item